Learn how zoledronic acid (Reclast) treats osteoporosis, what to expect from the infusion, and how to track results with a DEXA Scan in San Francisco at KALOS.
Zoledronic acid (also known as zoledronate) is a powerful medication widely used to treat osteoporosis and prevent fractures. Delivered as an intravenous (IV) infusion, it’s known for being one of the most effective long-acting osteoporosis treatments available today. But like any medication, it’s important to understand how it works, what the infusion process looks like, and what side effects you might experience.
This guide will walk you through everything you need to know about zoledronic acid (Reclast)—including how long it stays in your body, what to expect from the infusion, and how to manage potential side effects.
Zoledronic acid injection is usually given once a year via an IV infusion.
Zoledronic acid:
Unlike oral bisphosphonates (like alendronate), zoledronic acid stays in the body for years, continuing to protect bones long after the infusion.
Zoledronic acid side effects: how long do they last?
Most side effects peak within 24–48 hours and resolve in 3–4 days.
Zoledronic acid warnings include monitoring kidney function, dental health, and calcium/vitamin D status before treatment.
To evaluate how well zoledronic acid is working, you’ll need a DEXA scan:
At KALOS, our DEXA Scan San Francisco service provides fast, accurate results to help you and your provider make informed treatment decisions.
Considering or currently using zoledronic acid for osteoporosis? Get the full picture of how your bones are responding with a DEXA scan at KALOS. We make it easy to track bone density, fracture risk, and progress—so you can stay strong and informed.
Schedule your scan today at KALOS—your journey to data-driven bone health starts now.
Bay Area residents trust KALOS to deliver results. We proudly serve the entire Bay Area including the following locations: